Physician

George Kroumpouzos, MD PHD

According to 2025 Medicare claims, George Kroumpouzos, MD PHD (NPI: 1336121581) practices dermatology in the Boston, MA market, with the plurality of this provider's patient population coming from Plymouth, MA. This provider's primary affiliated billing organization is GK DERMATOLOGY, PC (NPI: 1578991113; TIN: 01-0779593) and primary practice location at 02190-1845.

Kroumpouzos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,312 traditional Medicare patients, billed 11,670 HCPCS/CPT codes, and received $794,854 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,154 prescription claims across 674 beneficiaries totaling $541,664 in drug costs, led by Otezla (Apremilast). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $88,354 to $541,664. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$397K$795K2015 Medicare payment: $571,951 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $598,283 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $578,106 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $617,689 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $697,041 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $543,625 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $734,886 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $767,872 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $758,934 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $794,854 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,37012,143$571,951
20161,42512,752$598,283
20171,35311,909$578,106
20181,29110,600$617,689
20191,25810,199$697,041
20201,0877,955$543,625
20211,10110,161$734,886
20221,19110,634$767,872
20231,21511,142$758,934
20241,31211,670$794,854

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$282K$565K2015 Drug cost: $88,354 (USD; Tot_Drug_Cst)2016 Drug cost: $116,300 (USD; Tot_Drug_Cst)2017 Drug cost: $168,178 (USD; Tot_Drug_Cst)2018 Drug cost: $173,905 (USD; Tot_Drug_Cst)2019 Drug cost: $116,696 (USD; Tot_Drug_Cst)2020 Drug cost: $101,124 (USD; Tot_Drug_Cst)2021 Drug cost: $109,209 (USD; Tot_Drug_Cst)2022 Drug cost: $172,573 (USD; Tot_Drug_Cst)2023 Drug cost: $564,920 (USD; Tot_Drug_Cst)2024 Drug cost: $541,664 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015254715$88,354
2016341868$116,300
20174151,091$168,178
20184431,162$173,905
20194191,124$116,696
2020368955$101,124
20214651,383$109,209
20225191,441$172,573
20235731,744$564,920
20246742,154$541,664

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7251,291$104
17110Destruction of skin growth, 1-14 growths581741$102
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8291,254$73
17000Destruction of precancer skin growth, 1 growth7961,102$45
17003Destruction of precancer skin growth, 2-14 growths6643,943$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast471,410$230,991
Dupixent PenDupilumab13420$65,853
TacrolimusTacrolimus722,446$11,567
Clobetasol PropionateClobetasol Propionate1544,988$9,036
Halobetasol PropionateHalobetasol Propionate2157,153$8,950

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for George Kroumpouzos, MD PHD?

Tedicare shows public-source Medicare data for George Kroumpouzos, MD PHD (NPI 1336121581), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George Kroumpouzos, MD PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George Kroumpouzos, MD PHD?

George Kroumpouzos, MD PHD is linked to GK DERMATOLOGY, PC (billing NPI 1578991113) in the available physician profile data.

Does George Kroumpouzos, MD PHD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.